6-Bromo-8-methoxy-3,4-dihydroisoquinolin-1(2H)-one, 98%, 250mg

4-(Dimethylamino)-1-(2-oxopropyl)pyridinium bromide, 250mg

4-Dimethylaminocinnamaldehyde>98.0%(T)25g

1-(3-Methoxy-4-methylphenyl)cyclopropan-1-amine hydrochloride, 100mg

5-Methyl-isoxazole-3-carboxylic acid hydrazide, 90.0%, 10g

4-Bromo-2-(piperazin-1-yl)thiazole, 95.0%, 5g

2-Phenylthiazole-4-carboxylic acid, 97.0%, 1g

Bicalutamide>98.0%(HPLC)(N)200mg

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile, 95.0%, 5g

2-Methyl-2,6-diazaspiro[3.4]octane dihydrochloride, 95%, 1g

1,4'-Bi-1H-pyrazole, 5-(dicyclohexylphosphino)-1',3',5'-triphenyl-, 97%, 250mg

5-Phenyl-3H-thieno[2,3-d]pyrimidin-4-one, 95.0%, 5g

Electroporation cuvettes 100 µl 50 pcs